Fliegerova K, Mahayri T, Sechovcova H, Mekadim C, Mrazek J, Jarosikova R
Front Microbiol. 2025; 15():1451054.
PMID: 39839113
PMC: 11747157.
DOI: 10.3389/fmicb.2024.1451054.
Ullah H, Arbab S, Tian Y, Chen Y, Liu C, Li Q
Front Immunol. 2024; 15:1413485.
PMID: 39144142
PMC: 11321976.
DOI: 10.3389/fimmu.2024.1413485.
Van Der Byl W, Nussing S, Peters T, Ahn A, Li H, Ledergor G
Immunity. 2024; 57(6):1324-1344.e8.
PMID: 38776918
PMC: 11807353.
DOI: 10.1016/j.immuni.2024.04.026.
Costanzo A, Clarke D, Holt M, Sharma S, Nagy K, Tan X
J Immunol. 2024; 212(7):1094-1104.
PMID: 38426888
PMC: 10944819.
DOI: 10.4049/jimmunol.2300769.
Klug N, Burke J, Scott E
J Immunol. 2024; 212(2):216-224.
PMID: 38166244
PMC: 10766078.
DOI: 10.4049/jimmunol.2300527.
Pancreatic draining lymph nodes (PLNs) serve as a pathogenic hub contributing to the development of type 1 diabetes.
Sun F, Yang C, Wang F, Rong S, Luo J, Lu W
Cell Biosci. 2023; 13(1):156.
PMID: 37641145
PMC: 10464122.
DOI: 10.1186/s13578-023-01110-7.
LFA-1/ICAM-1 Adhesion Pathway Mediates the Homeostatic Migration of Lymphocytes from Peripheral Tissues into Lymph Nodes through Lymphatic Vessels.
Guo J, Xu Z, Gunderson R, Xu B, Michie S
Biomolecules. 2023; 13(8).
PMID: 37627259
PMC: 10452152.
DOI: 10.3390/biom13081194.
Lymph node sharing between pancreas, gut, and liver leads to immune crosstalk and regulation of pancreatic autoimmunity.
Brown H, Komnick M, Brigleb P, Dermody T, Esterhazy D
Immunity. 2023; 56(9):2070-2085.e11.
PMID: 37557168
PMC: 11040372.
DOI: 10.1016/j.immuni.2023.07.008.
Nanotargeted Delivery of Immune Therapeutics in Type 1 Diabetes.
Jung S, Ben Nasr M, Bahmani B, Usuelli V, Zhao J, Sabiu G
Adv Mater. 2023; 35(40):e2300812.
PMID: 37357903
PMC: 10629472.
DOI: 10.1002/adma.202300812.
Virus induced dysbiosis promotes type 1 diabetes onset.
Morse Z, Simister R, Crowe S, Horwitz M, Osborne L
Front Immunol. 2023; 14:1096323.
PMID: 36742327
PMC: 9892191.
DOI: 10.3389/fimmu.2023.1096323.
Microbial dysbiosis in the gut drives systemic autoimmune diseases.
Mousa W, Chehadeh F, Husband S
Front Immunol. 2022; 13:906258.
PMID: 36341463
PMC: 9632986.
DOI: 10.3389/fimmu.2022.906258.
Islet-specific CD8 T cells gain effector function in the gut lymphoid tissues via bystander activation not molecular mimicry.
Okada M, Zhang V, Loaiza Naranjo J, Tillett B, Wong F, Steptoe R
Immunol Cell Biol. 2022; 101(1):36-48.
PMID: 36214093
PMC: 10092732.
DOI: 10.1111/imcb.12593.
Host-microbiota interactions shaping T-cell response and tolerance in type 1 diabetes.
Majumdar S, Lin Y, Bettini M
Front Immunol. 2022; 13:974178.
PMID: 36059452
PMC: 9434376.
DOI: 10.3389/fimmu.2022.974178.
Gut Microbiota, Leaky Gut, and Autoimmune Diseases.
Christovich A, Luo X
Front Immunol. 2022; 13:946248.
PMID: 35833129
PMC: 9271567.
DOI: 10.3389/fimmu.2022.946248.
Cathelicidin-related antimicrobial peptide protects against enteric pathogen-accelerated type 1 diabetes in mice.
Jia L, Li J, Zhang M, Liu H, Ren Z, Dong X
Theranostics. 2022; 12(7):3438-3455.
PMID: 35547774
PMC: 9065195.
DOI: 10.7150/thno.61433.
Infection with the enteric pathogen C. rodentium promotes islet-specific autoimmunity by activating a lymphatic route from the gut to pancreatic lymph node.
Poysti S, Toivonen R, Takeda A, Silojarvi S, Yatkin E, Miyasaka M
Mucosal Immunol. 2022; 15(3):471-479.
PMID: 35140345
PMC: 9038524.
DOI: 10.1038/s41385-022-00490-2.
Neutrophil Extracellular Traps Caused by Gut Leakage Trigger the Autoimmune Response in Nonobese Diabetic Mice.
You Q, Shen Y, Wu Y, Li Y, Liu C, Huang F
Front Immunol. 2022; 12:711423.
PMID: 35111148
PMC: 8801438.
DOI: 10.3389/fimmu.2021.711423.
Virus Infection Is an Instigator of Intestinal Dysbiosis Leading to Type 1 Diabetes.
Morse Z, Horwitz M
Front Immunol. 2021; 12:751337.
PMID: 34721424
PMC: 8554326.
DOI: 10.3389/fimmu.2021.751337.
Changes in the gut microbiota: a possible factor influencing peripheral blood immune indexes in non-obese diabetic mice.
Wu Y, You Q, Fei J, Wu J
Antonie Van Leeuwenhoek. 2021; 114(10):1669-1682.
PMID: 34370135
DOI: 10.1007/s10482-021-01632-5.
Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes.
Stojanovic I, Saksida T, Miljkovic D, Pejnovic N
Front Immunol. 2021; 12:653560.
PMID: 34149694
PMC: 8209467.
DOI: 10.3389/fimmu.2021.653560.